Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.85
Delayed Data
As of Jun 15
 -0.025 / -1.33%
Today’s Change
1.42
Today|||52-Week Range
3.19
-8.42%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Suzdak Peter David
Chief Executive Officer
Gift8/16/201710,000$1.99$19.9K-5.13%
Suzdak Peter David
Chief Executive Officer
Buy2/28/20186,250$0.00$0.00+15.63%
Benaim Ely
Chief Medical Officer
Buy2/28/20182,375$0.00$0.00+15.63%
Nolan Lisa M
Chief Business Officer
Buy2/28/20181,625$0.00$0.00+15.63%